The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. Keeping that in mind, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where its enthusiasm might be excessive.
Two Stocks to Sell:
EverQuote (EVER)
Consensus Price Target: $29.60 (18.3% implied return)
Aiming to simplify a once complicated process, EverQuote (NASDAQ: EVER) is an online insurance marketplace where consumers can compare and purchase various types of insurance from different providers
Why Does EVER Give Us Pause?
- High marketing expenses suggest it needs to spend heavily on new customer acquisition to sustain momentum
At $25.03 per share, EverQuote trades at 5.6x forward EV/EBITDA. If you’re considering EVER for your portfolio, see our FREE research report to learn more.
BrightView (BV)
Consensus Price Target: $15.45 (34.3% implied return)
An official field consultant for Major League Baseball, BrightView (NYSE: BV) offers landscaping design, development, and maintenance.
Why Is BV Risky?
- Flat sales over the last two years suggest it must find different ways to grow during this cycle
- Earnings per share fell by 15.3% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
- Underwhelming 2.9% return on capital reflects management’s difficulties in finding profitable growth opportunities
BrightView is trading at $11.51 per share, or 20.3x forward P/E. Read our free research report to see why you should think twice about including BV in your portfolio.
One Stock to Buy:
Vertiv (VRT)
Consensus Price Target: $338.15 (28.3% implied return)
Formerly part of Emerson Electric, Vertiv (NYSE: VRT) manufactures and services infrastructure technology products for data centers and communication networks.
Why Will VRT Beat the Market?
- Average organic revenue growth of 24.2% over the past two years demonstrates its ability to expand independently without relying on acquisitions
- Free cash flow margin expanded by 32.1 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
- Rising returns on capital show management is finding more attractive investment opportunities
Vertiv’s stock price of $263.60 implies a valuation ratio of 34.9x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
